Patterns and costs of hospital care for coronary heart disease related and not related to diabetes
- PMID: 9470868
- PMCID: PMC1892321
- DOI: 10.1136/hrt.78.6.544
Patterns and costs of hospital care for coronary heart disease related and not related to diabetes
Abstract
Objective: To describe the epidemiology and costs of coronary heart disease (CHD) requiring hospital admission, with particular reference to diabetes.
Setting: The former South Glamorgan Health Authority, South Wales.
Methods: Routine hospital activity data were record linked and all diabetic and non-diabetic individuals over a four year period (1991-95) were identified. A cost weight was included for each admission based on diagnosis related groups.
Results: There were 10,214 patients admitted with a primary diagnostic code for CHD, representing an incidence of 6.3 per 1000 per annum. Including all CHD and non-CHD admissions, these individuals were responsible for 17% of acute inpatient activity. Men had a consistently higher age specific prevalence of CHD than women. The age adjusted relative risk of CHD for patients with diabetes compared with those without was 4.1 for men and 5.5 for women. Patients with diabetes accounted for 16.9% of CHD related admissions and had a fourfold increased probability of undergoing a cardiac procedure. The total cost of CHD was estimated to be 6% of NHS revenue at 1994-95 pay and prices. Patients with diabetes were responsible for 16% of this expenditure. This translated to an estimated NHS acute hospital expenditure for CHD of 1.1 billion pounds per year at 1994-95 pay and prices.
Conclusions: CHD was responsible for a larger proportion of NHS expenditure than had previously been reported. Nearly one in five acute hospital admissions were for patients whose condition included cardiac problems. The relation between diabetes and CHD was particularly evident, and may offer opportunities for disease prevention.
Figures





Similar articles
-
The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.Diabetes Care. 1998 Jan;21(1):42-8. doi: 10.2337/diacare.21.1.42. Diabetes Care. 1998. PMID: 9538969
-
Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.Public Health. 2006 Dec;120(12):1140-8. doi: 10.1016/j.puhe.2006.10.012. Epub 2006 Nov 3. Public Health. 2006. PMID: 17084425
-
The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.Value Health. 2001 Sep-Oct;4(5):370-5. doi: 10.1046/j.1524-4733.2001.45049.x. Value Health. 2001. PMID: 11705127
-
Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region.Diabet Med. 2010 Sep;27(9):1066-73. doi: 10.1111/j.1464-5491.2010.03086.x. Diabet Med. 2010. PMID: 20722682
-
[Epidemiology of cardio-vascular complications of diabetes].Diabetes Metab. 1999 Jun;25 Suppl 3:12-20. Diabetes Metab. 1999. PMID: 10421988 Review. French.
Cited by
-
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.Heart. 2005 Apr;91(4):472-7. doi: 10.1136/hrt.2004.042465. Heart. 2005. PMID: 15772203 Free PMC article.
-
Preventing ischaemic heart disease in one general practice: from one patient, through clinical audit, needs assessment, and commissioning into quality improvement.BMJ. 1998 Oct 24;317(7166):1120-3; discussion 1124. doi: 10.1136/bmj.317.7166.1120. BMJ. 1998. PMID: 9784449 Free PMC article. Review. No abstract available.
-
A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.Pharmacoeconomics. 2003;21 Suppl 1:25-32. doi: 10.2165/00019053-200321001-00003. Pharmacoeconomics. 2003. PMID: 12648032 Clinical Trial.
-
Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.Pharmacoeconomics. 2009;27(6):479-90. doi: 10.2165/00019053-200927060-00004. Pharmacoeconomics. 2009. PMID: 19640011
-
Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin.Heart. 2006 Feb;92(2):196-200. doi: 10.1136/hrt.2004.058339. Epub 2005 May 9. Heart. 2006. PMID: 15883133 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources